CRISPR THERAPEUTICS AG

CUSIP: h17182108 Class: COM

Reynders McVeigh Capital Management, LLC's Holding History (CIK: 0001455969)

Note: Option positions (PUT/CALL) are excluded.

Q4 2023
Shares 92,048 Value ($000) $6 Avg Close — Range —
Q3 2023
Shares 76,178 Value ($000) $3 Avg Close — Range —
Q2 2023
Shares 49,998 Value ($000) $3 Avg Close — Range —
Q1 2023
Shares 18,904 Value ($000) $1 Avg Close — Range —
Q3 2022
Shares 3,085 Value ($000) $202 Avg Close — Range —
Q1 2022
Shares 4,680 Value ($000) $294 Avg Close — Range —
Q4 2021
Shares 2,865 Value ($000) $217 Avg Close — Range —
Q3 2021
Shares 2,700 Value ($000) $302 Avg Close — Range —
Q2 2021
Shares 2,605 Value ($000) $422 Avg Close — Range —
Q1 2021
Shares 2,460 Value ($000) $300 Avg Close — Range —
Q4 2020
Shares 2,440 Value ($000) $374 Avg Close — Range —
Q3 2020
Shares 2,490 Value ($000) $208 Avg Close — Range —